About me
Ann Marie Hake is a board-certified Neurologist with fellowship training in neurodegenerative diseases and postgraduate training in medical informatics. In her current role at Lilly, she is a clinical research physician in the Digital Health R&D group, as well as the Vice Chair of the Lilly Bioethics Advisory Committee. Previously at Lilly she led late- and early-phase clinical trials and provided medical leadership in Medical Affairs in neurodegeneration and in migraine. Prior to joining Lilly, she was an Associate Professor of Clinical Neurology at the Indiana University School of Medicine, where she continues on the adjunct faculty, serves on the Institutional Review Board, and sees neurology outpatients twice monthly.
